- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 29, 2016
Product Development
Infectious enthusiasm
How oncolytic viruses are coming of age in cancer immunotherapy combinations
BioCentury | Jan 31, 2011
Strategy
Lysing what it sees
Amgen buying BioVex for OncoVEX immunotherapy based on Phase II melanoma data
Items per page:
1 - 9 of 9